Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 46


Isolation of nuclei from skeletal muscle satellite cells and myofibers for use in chromatin immunoprecipitation assays.

Ohkawa Y, Mallappa C, Vallaster CS, Imbalzano AN.

Methods Mol Biol. 2012;798:517-30. doi: 10.1007/978-1-61779-343-1_31.


Pyrosequencing-based DNA methylation profiling of Fanconi anemia/BRCA pathway genes in laryngeal squamous cell carcinoma.

Szaumkessel M, Richter J, Giefing M, Jarmuz M, Kiwerska K, Tönnies H, Grenman R, Heidemann S, Szyfter K, Siebert R.

Int J Oncol. 2011 Aug;39(2):505-14. doi: 10.3892/ijo.2011.1039. Epub 2011 May 11.


Oridonin induces apoptosis and senescence in colorectal cancer cells by increasing histone hyperacetylation and regulation of p16, p21, p27 and c-myc.

Gao FH, Hu XH, Li W, Liu H, Zhang YJ, Guo ZY, Xu MH, Wang ST, Jiang B, Liu F, Zhao YZ, Fang Y, Chen FY, Wu YL.

BMC Cancer. 2010 Nov 6;10:610. doi: 10.1186/1471-2407-10-610.


Global histone modification patterns as prognostic markers to classify glioma patients.

Liu BL, Cheng JX, Zhang X, Wang R, Zhang W, Lin H, Xiao X, Cai S, Chen XY, Cheng H.

Cancer Epidemiol Biomarkers Prev. 2010 Nov;19(11):2888-96. doi: 10.1158/1055-9965.EPI-10-0454. Epub 2010 Sep 14.


Induction of epigenetic alterations by dietary and other environmental factors.

Mathers JC, Strathdee G, Relton CL.

Adv Genet. 2010;71:3-39. doi: 10.1016/B978-0-12-380864-6.00001-8. Review.


Promoter hypermethylation in prostate cancer.

Park JY.

Cancer Control. 2010 Oct;17(4):245-55. Review.


Identification of differential and functionally active miRNAs in both anaplastic lymphoma kinase (ALK)+ and ALK- anaplastic large-cell lymphoma.

Merkel O, Hamacher F, Laimer D, Sifft E, Trajanoski Z, Scheideler M, Egger G, Hassler MR, Thallinger C, Schmatz A, Turner SD, Greil R, Kenner L.

Proc Natl Acad Sci U S A. 2010 Sep 14;107(37):16228-33. doi: 10.1073/pnas.1009719107. Epub 2010 Aug 30.


Whole blood-derived miRNA profiles as potential new tools for ovarian cancer screening.

Häusler SF, Keller A, Chandran PA, Ziegler K, Zipp K, Heuer S, Krockenberger M, Engel JB, Hönig A, Scheffler M, Dietl J, Wischhusen J.

Br J Cancer. 2010 Aug 24;103(5):693-700. doi: 10.1038/sj.bjc.6605833. Epub 2010 Aug 3.


Inbreeding and epigenetics: beneficial as well as deleterious effects.

Nebert DW, Gálvez-Peralta M, Shi Z, Dragin N.

Nat Rev Genet. 2010 Sep;11(9):662. doi: 10.1038/nrg2664-c2. Epub 2010 Jul 27. No abstract available.


Chromatin remodeling in mammary gland differentiation and breast tumorigenesis.

Huang TH, Esteller M.

Cold Spring Harb Perspect Biol. 2010 Sep;2(9):a004515. doi: 10.1101/cshperspect.a004515. Epub 2010 Jul 7. Review.


Direct DNA methylation profiling using methyl binding domain proteins.

Yu Y, Blair S, Gillespie D, Jensen R, Myszka D, Badran AH, Ghosh I, Chagovetz A.

Anal Chem. 2010 Jun 15;82(12):5012-9. doi: 10.1021/ac1010316.


Differential expression of specific microRNA and their targets in acute myeloid leukemia.

Cammarata G, Augugliaro L, Salemi D, Agueli C, La Rosa M, Dagnino L, Civiletto G, Messana F, Marfia A, Bica MG, Cascio L, Floridia PM, Mineo AM, Russo M, Fabbiano F, Santoro A.

Am J Hematol. 2010 May;85(5):331-9. doi: 10.1002/ajh.21667.


Genome-wide analysis of histone modifications in human pancreatic islets.

Bhandare R, Schug J, Le Lay J, Fox A, Smirnova O, Liu C, Naji A, Kaestner KH.

Genome Res. 2010 Apr;20(4):428-33. doi: 10.1101/gr.102038.109. Epub 2010 Feb 24.


The promises and challenges of epigenetic epidemiology.

Michels KB.

Exp Gerontol. 2010 Apr;45(4):297-301. doi: 10.1016/j.exger.2009.12.011. Epub 2009 Dec 23.


Epigenetics in cancer.

Sharma S, Kelly TK, Jones PA.

Carcinogenesis. 2010 Jan;31(1):27-36. doi: 10.1093/carcin/bgp220. Epub 2009 Sep 13. Review.


Genetic lesions in chronic lymphocytic leukemia: clinical implications.

Montserrat E, Moreno C.

Curr Opin Oncol. 2009 Nov;21(6):609-14. doi: 10.1097/CCO.0b013e328331b702. Review.


Quantitative analysis of DNA methylation after whole bisulfitome amplification of a minute amount of DNA from body fluids.

Vaissière T, Cuenin C, Paliwal A, Vineis P, Hoek G, Krzyzanowski M, Airoldi L, Dunning A, Garte S, Hainaut P, Malaveille C, Overvad K, Clavel-Chapelon F, Linseisen J, Boeing H, Trichopoulou A, Trichopoulos D, Kaladidi A, Palli D, Krogh V, Tumino R, Panico S, Bueno-De-Mesquita HB, Peeters PH, Kumle M, Gonzalez CA, Martinez C, Dorronsoro M, Barricarte A, Navarro C, Quiros JR, Berglund G, Janzon L, Jarvholm B, Day NE, Key TJ, Saracci R, Kaaks R, Riboli E, Hainaut P, Herceg Z.

Epigenetics. 2009 May 16;4(4):221-30. Epub 2009 May 24.


A multicenter, double-blinded validation study of methylation biomarkers for progression prediction in Barrett's esophagus.

Jin Z, Cheng Y, Gu W, Zheng Y, Sato F, Mori Y, Olaru AV, Paun BC, Yang J, Kan T, Ito T, Hamilton JP, Selaru FM, Agarwal R, David S, Abraham JM, Wolfsen HC, Wallace MB, Shaheen NJ, Washington K, Wang J, Canto MI, Bhattacharyya A, Nelson MA, Wagner PD, Romero Y, Wang KK, Feng Z, Sampliner RE, Meltzer SJ.

Cancer Res. 2009 May 15;69(10):4112-5. doi: 10.1158/0008-5472.CAN-09-0028. Epub 2009 May 12.


LINE-1 methylation in plasma DNA as a biomarker of activity of DNA methylation inhibitors in patients with solid tumors.

Aparicio A, North B, Barske L, Wang X, Bollati V, Weisenberger D, Yoo C, Tannir N, Horne E, Groshen S, Jones P, Yang A, Issa JP.

Epigenetics. 2009 Apr 1;4(3):176-84. Epub 2009 Apr 6.

Supplemental Content

Support Center